Skip to main content
Michael Brenner, MD, Rheumatology, Boston, MA

MichaelBBrennerMD

Rheumatology Boston, MA

Theodore Bevier Bayles Professor of Medicine, Brigham and Women's Hospital

Dr. Brenner is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Brenner's full profile

Already have an account?

  • Office

    Brigham And Women's Hospital Rheumatology Immunology &
    60 Fenwood Rd. Rm 6002U
    Boston, MA 02115
    Phone+1 617-525-1000

Education & Training

  • UCLA David Geffen School of Medicine/UCLA Medical Center
    UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Rheumatology, 1979 - 1982
  • Vanderbilt University Medical Center
    Vanderbilt University Medical CenterResidency, Internal Medicine, 1975 - 1979
  • Vanderbilt University School of Medicine
    Vanderbilt University School of MedicineClass of 1975

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1979 - Present
  • MA State Medical License
    MA State Medical License 1985 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Rheumatology

Awards, Honors, & Recognition

  • Fellow (FACR) American College of Rheumatology

Publications & Presentations

PubMed

Journal Articles

  • Metabolic Reprogramming of Natural Killer Cells in Obesity Limits Antitumor Responses  
    Ali Tavakkoli, Michael B Brenner, Kevin Wei, Ashley Vernon, Nature
  • Plateletpheresis-Associated Lymphopenia in Frequent Platelet Donors  
    Michael B Brenner, John M Gansner, A Helena Jonsson, Dan L Longo, Jason M Schenkel, Deepak A Rao, Richard M Kaufman, Nancy Berliner, Duane R Wesemann, Blood
  • High-Throughput Identification of Noncoding Functional SNPs via Type IIS Enzyme Restriction  
    Soumya Raychaudhuri, Jing Cui, Michael B Brenner, Peter A Nigrovic, Nature
  • Join now to see all

Press Mentions

  • Newborn Bio Business Mestag Therapeutics Raises $11m Seed Cash
    Newborn Bio Business Mestag Therapeutics Raises $11m Seed CashApril 26th, 2021
  • Mestag Therapeutics Launches with Seed Financing of $11 Million to Develop Therapeutics Targeting Activated Fibroblast Populations Across Inflammatory Disease and Cancer
    Mestag Therapeutics Launches with Seed Financing of $11 Million to Develop Therapeutics Targeting Activated Fibroblast Populations Across Inflammatory Disease and CancerApril 20th, 2021
  • U.S. Department of Defense Awards $3.3 Million Grant to Alivio Therapeutics
    U.S. Department of Defense Awards $3.3 Million Grant to Alivio TherapeuticsSeptember 12th, 2018
  • Join now to see all

Professional Memberships